← Back to Search

Procedure

Standard Percutaneous Nephrolithotomy (sPCNL) for Kidney Stones

N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative period, 24 hours on average.
Awards & highlights

Study Summary

This trial will compare the outcomes of two different procedures for treating renal stones - standard PCNL and mini-PCNL. The goal is to provide guidance on which procedure is better in the US population, and to study the safety and costs of each procedure.

Eligible Conditions
  • Kidney Stones

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative period, 24 hours on average.
This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative period, 24 hours on average. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Loss
Secondary outcome measures
Anesthesia Time
ED Visits
Hospital Stay Time
+14 more

Trial Design

2Treatment groups
Active Control
Group I: Standard Percutaneous Nephrolithotomy (sPCNL)Active Control1 Intervention
The first arm will consist of a Standard of Care standard percutaneous nephrolithotomy (sPCNL)- performed using a 30 Fr access sheath following balloon dilation.
Group II: Minimally Invasive Percutaneous Nephrolithotomy (MIP)Active Control1 Intervention
The second arm will consist of a Standard of Care mini percutaneous nephrolithotomy (mPCNL)- performed using an 18 Fr access sheath following either balloon dilation or dilation using a single step metal dilator.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,123 Previous Clinical Trials
1,552,749 Total Patients Enrolled
5 Trials studying Kidney Stones
3,622 Patients Enrolled for Kidney Stones
Manoj Monga, M.D.Study ChairUCSD Medical Center, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many medical centers are conducting this clinical trial?

"There are 6 trial sites that are currently running the study, such as Mayo Clinic in Phoenix, Vanderbilt University Medical Center in Nashville and University Of British Columbia in Vancouver. Other locations include..."

Answered by AI

How many participants is the medical trial currently accommodating?

"This clinical trial necessitates 90 eligible individuals to be recruited from different locations, such as Mayo Clinic in Phoenix and Vanderbilt University Medical Center in Nashville. To qualify for the study, each participant must meet specific inclusion criteria."

Answered by AI

What is the current status of recruitment for this trial?

"Affirmative. According to the clinicaltrials.gov database, this clinical trial is currently in search of volunteers and was initially posted on January 15th 2021 with a most recent update on July 12th 2022. 90 participants are needed across 6 different sites."

Answered by AI
Recent research and studies
~21 spots leftby May 2025